Close Menu


The financing round brings the total amount of funding for Micronoma, a developer of microbiome-based cancer detection technology, to $6.5 million.

In Science this week: functional importance of NOVA1 in human evolution, and more.

Researchers used CRISPR to reintroduce an archaic variant of NOVA1 into cortical organoids to study how a human-specific variant may have affected evolution.

The study's findings could also point to potential treatment candidates for post-traumatic stress disorder, the researchers said.

The company has developed an analyzer to run PCR, immunochemistry, and cytometry tests at the same time for a variety of diseases including COVID-19.

The researchers found likely deleterious de novo tandem repeat mutations that were more common among individuals with autism spectrum disorder.

In Science this week: updated reference genome assembly for the rhesus macaque, and more.

In Genome Research this week: approach to predict gene expression from single-cell DNA methylation profiles, oral microbiome of children with cavities, and more.

The Washington Post reports on efforts to study human stem cells in microgravity.

Follow the Spread

San Diego researchers have received funds to sequence SARS-CoV-2 in the region, NBC 7 San Diego reports.


SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.